WB seeks board approval for US$12b vaccine financing plan | World | China Daily

Global competition for early coronavirus vaccine doses is already fierce, months ahead of any approvals, as wealthy countries move to secure supplies. The US government has pledged over US$3 billion to secure hundreds of millions of doses of vaccines under development by Britain’s AstraZeneca Plc and by US drug giant Pfizer Inc and Germany’s BioNTech. READ MORE: WHO: Global virus toll could hit 2m before vaccine in wide use Malpass said the World Bank plan aimed to put poor and middle-income countries, where the virus is spreading most rapidly, on the same footing as richer countries by ensuring they have…